# Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910

> **NCT01961414** · PHASE4 · UNKNOWN · sponsor: **Palmetto Retina Center, LLC** · enrollment: 45 (estimated)

## Conditions studied

- Exudative Age-related Macular Degeneration

## Interventions

- **DRUG:** Aflibercept

## Key facts

- **NCT ID:** NCT01961414
- **Lead sponsor:** Palmetto Retina Center, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2016-03
- **Final completion:** 2016-07
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2015-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01961414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01961414, "Treat and Extend Therapy Study Using Intravitreal Aflibercept for Patients Exited From Protocol VGFT-OD 0910". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT01961414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*